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Gabriella Szucs4, Peter Szodoray5 and Adam Kemeny-Beke1
Abstract
The human precorneal tear film is a special body fluid, since it is a complex mixture of proteins, lipids, small bioactive
molecules, and their concentrations and relative distribution represent not only the metabolic state of the ocular surface
but also the systemic and local homeostasis of the outer eye and the human body. This suggests that biochemical analysis
of the precorneal tear film composition may provide a non-invasive tool for diagnosis and monitoring of disease pro-
gression or treatment efficacy in human medicine. However, collecting tears is demanding, and obtaining reproducible
and unaltered samples is challenging because of the small sample volumes of tears. Several methods are available for tear
collection as a preparatory step of precorneal tear film analysis, and the collection method used has to be assessed since
it has a critical impact on the effectiveness of the assays and on the quality of the results. Each sampling method has
advantages and disadvantages; therefore, it is not easy to choose the appropriate collecting method for tear collection.
To overcome these limitations various methods have been recommended by different authors for special aspects of
specific tests. The aim of our review was to evaluate tear sampling methods with regard to our ongoing biochemical
analysis.
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Introduction
Precorneal tear ﬁlm (PCTF) as a biological ﬂuid is very
easily accessible with non- or very low-invasive meth-
ods at a relatively low cost. It not only lubricates the
ocular surface carrying secreted molecules from corneal
epithelial cells and tissues producing tear components
but can also represent the physiological status of the
body. Due to the very limited number of samples and
the relative instability of the components, sample col-
lection is a critical step in tear research and diagnostics.
In the present review, we summarize the most com-
monly used tear sampling methods, emphasizing their
advantages and disadvantages based particularly on the
subsequent analysis.
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Tear biology: Functions and pathological
relations of the human tear
The tear ﬁlm covering the ocular surface has several
functions including protecting the external surface of
the eyeball thus constituting a mechanical and anti-
microbial barrier. It lubricates the eye surface and
nourishes also the avascular tissues of the cornea.
Since the tear ﬁlm is also an optical refractive
medium, its stability is pivotal in achieving appropriate
vision.1–3
The human tear ﬁlm is composed of two layers: there
is a lipid layer and an aqueous layer that include soluble
proteins and mucins and also membrane-bound
mucins.3 The lipid component, which originates from
the Meibomian glands of the tarsus, forms the superﬁ-
cial layer of the tear ﬁlm. The aqueous component is
primarily secreted by the lacrimal gland. This is the
thickest layer, which contains water, electrolytes and
diverse proteins, peptides and glycoproteins. Mucins,
which are glycoproteins expressed by epithelial tissues
of mucous surfaces, protect tissues since they are anti-
oxidants, provide lubrication and inhibit bacterial
adherence.4–7
Under normal conditions, the PCTF ﬂow in humans
is around 0.5–2.2 lL/min with a turnover rate of
approximately 16% per minute.8 PCTF volume present
in the human eye is 7–10 lL.9 A continuous cycle of
tear production, evaporation, drainage and absorption
results in a dynamic equilibrium of the ocular surface.
Osmolarity is the index of tear dynamics and is mainly
determined by the electrolytes of the aqueous phase of
the PCTF. Under normal conditions the expected range
is 302 8 mOsm/L. The dry eye workshop in 2007
identiﬁed increased tear osmolarity and tear ﬁlm
instability as ‘core mechanisms’ of DE, regardless of
the oetiology.4,6 DE studies using the TearLab
Osmolarity System have found that the mean tear
osmolarities of the mild-to-moderate and severe DE
patients were 315.0 11.4 and 336.4 22.3mOsm/L,
respectively.5
Furthermore, tears have to be viscous enough to
protect and lubricate the surface, but not too viscous
so as to avoid ocular surface damages of high shear
forces caused by blinking. The normal tear ﬂuid has a
viscosity of 1.3–5.9 cP.7
The approximate properties of normal tear ﬂuid are
outlined in Table 1.
Irritating stimuli like environmental ﬂuctuations,
diurnal patterns and physiological status indicate
reﬂex tear secretion via activation of the corneal
nerves.8–12 Open and closed eye PCTF diﬀer in com-
position and origin, hence eye closure also inﬂuences
the result of tear analysis.13
Changes in tear composition are associated with
many ocular diseases, such as dry eye syndrome,
Sjo¨gren’s syndrome, diabetic retinopathy, glaucoma,
Meibomian gland dysfunction, autoimmune thyroid
eye disease, pterygium, keratoconus, ocular rosacea,
blepharitis, as well as various systemic diseases such
as inﬂammatory diseases and infections, diabetes melli-
tus, allergies, Parkinson’s disease and certain types of
cancers (breast, lung, prostate).14–17 Despite the fact
that some biochemical properties (e.g. pH or osmolal-
ity) of tears and serum are similar, the protein compos-
ition, as well as the relative and absolute amount of the
components are diﬀerent. For example, Vitamin A con-
centration in tears is remarkably higher than in serum.
Similarly, the ﬁbronectin content of PCTF is one order
of magnitude higher than that of serum.18 Therefore,
tears should be considered a unique body ﬂuid. Table 2
summarizes data of tear ﬁlm lipid layers, i.e. their
origin, components and main roles (Table 2).
Major bioactive components of PCTF
Despite its small volume, tear ﬁlm is a remarkably com-
plex biological ﬂuid consisting of peptides, electrolytes,
lipids, carbohydrates, salts and small bioactive mol-
ecules such as amino acids, nucleosides, vitamins,
etc.10,19 Normal tears have a total protein concentra-
tion of approximately 7 g/L and they contain hundreds
of diﬀerent proteins, though the method of tear collec-
tion greatly inﬂuences the relative proportion of the
proteins present in any individual tear sample, as clar-
iﬁed in the early 1980s.20–22 Many of the tear proteins
play an important role in corneal wound healing,
inﬂammatory processes and corneal protection against
various pathogens.23
The most frequent proteins detected in tear samples
include lactoferrin, lysozyme, secretory immunoglobulin
Table 1. Properties of precorneal tear film (PCTF).
Origin Lacrimal functional unit: the main
and accessory lacrimal glands;
the ocular surface: cornea, con-
junctiva and Meibomian glands,
the eyelids, the interconnecting
sensory and motor nerves
Volume 7–10 lL
Flow (secretion velocity) 0.5–2.2 lL/min
Osmolarity 4290 mOsmol/L
Turnover rate 16%/min
Layers (1) Aqueous, including soluble
proteins and mucins and
membrane-bound mucins
(2) Lipid/oily
Thickness 3–11 lm
Total protein concentration 7 g/L
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A (sIgA), lipocalin, superoxide dismutase, cystatins and
a1-protease inhibitor. These proteins account for more
than 90% of all tear proteins.2,24,25 In the early years,
tear ﬁlm protein proﬁles were characterized using gel
electrophoresis and Edman degradation.26–28 Later,
sensitive immunoassay-based methods identiﬁed other
proteins in mammals’ tears, including growth factors,
neurotrophic factors, cytokines and cell adhesion
molecules, matrix metalloproteinases, immunoglobulins
and insulin.29,30
Prospects for the future: Tear diagnostics
Body ﬂuid analysis is a widely accepted, readily
repeated, convenient and low cost method in diagnos-
tics. Biomarker screening of various body ﬂuids may
have potential beneﬁts not only for the examination
of physiological processes but also for the early diag-
nosis and eﬀective therapy of several diseases. Fluid
biomarkers include macromolecules such as lipids,
proteins, RNA and DNA, as well as cells such as
immune, endothelial or even cancer cells.31
Tears, a body ﬂuid exposed to both internal and
external environment, contain an amazing amount of
molecular information, which is useful for the diagno-
sis, prognosis and treatment of ocular surface diseases.
This may promote the development of personalized
medicine and the utilization of biomarkers in certain
diseases.10
Tear collection methods and their application
in practice
Quantitative determination of tear proteins is of
increasing interest in ophthalmology, but still there
remains a technical problem due to small sample
volumes available and the complexity of sample
composition.32 Tear sampling is deﬁnitely a major chal-
lenge and has the greatest signiﬁcant inﬂuence on the
precision and reproducibility of the analytical results.
Direct sampling methods. Regarding the direct sampling
method, microcapillary tubes (MCT) or micropipettes
are used for sampling and this manner frequently
requires previous stimulation or instillation of diﬀerent
volumes of saline (100–200 lL) into the cul-de-sac and
collecting after suﬃcient mixing. This procedure can
cause dilution and may not permit collection of samples
from speciﬁc sites of the ocular surface.33 Kalsow et al.
investigated tear cytokine response to multipurpose
solutions in contact lens wear. Prior to contact lens
removal, non-stimulated tears (NST) were collected
from each eye from the inferior tear meniscus between
the 6 o’clock and lateral canthus positions using a 10 lL
ﬂame-polished glass micropipette. Following collection,
a 5.5 lL volume of tear was immediately transferred to
a sterile 0.2mL tube containing 49.5 lL of storage
solution to produce a 1:10 tear dilution for immediate
storage at 80C.34
Table 2. Layers of tears: Origins, components and main roles.
Layers of the PCTF Produced by/origin Consists of/components Main roles
Aqueous layer
Mucous part: the
innermost, thin-
nest layer
(0.05 lm)
Aqueous part:
the thickest layer
(almost 7lm)
Goblet cells, corneal
and conjunctival
epithelia
Main lacrimal gland,
accessory lacrimal
glands of Krause
and Wolfring
Secreted and transmembrane mucins,
immunoglobulins, salts, urea,
enzymes, glucose, leukocytes
Water, antimicrobial agents, cyto-
kines, hormones, immunoglobulins,
growth factors, neurotrophic fac-
tors, cell adhesion molecules, matrix
metalloproteinases, insulin, vitamins,
electrolytes (Naþ, Kþ, Ca2þ, Mg2þ,
Zn2þ, Mn2þ, Cl, HCO3, PO43),
proteins (60–500 different proteins
had been identified. Most frequent
ones: lactoferrin, lysozyme, sIgA,
lipocalin, superoxide dismutase,
cystatins, and a1-protease inhibitor)
Protection against pathogens and
debris, increasing stability of the
overlying tear film, regulation of
epithelial growth, cellular signalling,
facilitation of the movements of the
lids and globe without damage,
transport of proteins
Lubricating the ocular surface,
washing away foreign bodies, nour-
ishing the avascular cornea, anti-
microbial activity, ocular surface
health/balance and epithelial integrity
Lipid layer
the outermost
layer (0.1 lm)
Meibomian glands,
glands of Moll and
Zeiss, lacrimal
glands, epithelial
cells
Polar lipids, such as phospholipids and
sphingolipids
Non-polar lipids, such as wax esters,
sterol esters, triglycerides
Formation of a polar surfactant layer,
reducing evaporation of the under-
lying aqueous phase in the open eye,
providing a smooth optical surface,
avoiding contamination of the tear
film by skin lipids and organisms
PCTF: precorneal tear film.
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In 2012, Guyette et al. compared low-abundance
biomarker concentrations in capillary-collected NST
and washout (WO) tears of aqueous-deﬁcient and
normal patients. Ten-microliter polished micropipettes
were used to collect tears from the inferior marginal
strip taking great care in minimizing ocular surface con-
tact. Tear collection rate was continuously monitored.
Individual NST samples were collected in 10min ali-
quots and then immediately transferred to a sterile
polymerase chain reaction (PCR) tube. An equal
volume of assay buﬀer was added and the sample was
stored at 86C. A total of at least 6.5 lL NST was
collected from each study participant; each 10min ali-
quot was stored without delay in a separate PCR tube.
Prior to WO tear sample collection 10 lL sterile physio-
logic saline solution was added to the lower conjunctiva
by a digital pipette. The patient was instructed to gently
close their eyes and avoid any eye movements for 1min.
Tears were then collected using the same method as for
NST samples, but a shorter collection time of 5min per
aliquot was used to make up the 6.5lL minimum
volume requirement. Tear collection volume and time
were continually monitored to measure the tear collec-
tion rate.35
There have been several research projects in dry eye
syndrome and today emphasis in dry eye research has
shifted towards the role of inﬂammation in the anterior
surface of the eye.36 Since inﬂammatory mediators ori-
ginating from various ocular surface sources and the
main lacrimal gland do not constitute a totally homo-
genous mix the way tears are collected can inﬂuence the
resulting biomarker proﬁle. NST from the inferior mar-
ginal strip covers a broader spectrum of the sources,
whereas stimulated tear (ST) samples contain a higher
proportion of the lacrimal gland secretion.1 Explicit
protein proﬁle diﬀerences between NST and ST dem-
onstrate that these two sample types are not equiva-
lent.37,38 Although NST represents speciﬁcally the
inﬂammatory status of the ocular surface, the volume
of NST is limited, especially in aqueous deﬁcient dry
eye (ADDE). Even though tear sampling frequently
makes use of capillaries as they are less irritating and
the resulting sample is an exact representative concen-
tration of molecules, the main limitation of the method
is the volume of the sample (2–3lL) to be gained.8
One way to increase the available tear sample
volume is adding ﬂuid (e.g. sterile saline) to the eye
prior to sample collection, eﬀectively ‘washing out’
ocular surface molecules.39,40 Validity of the WO
method depends on the extent to which it changes the
NST biomarker proﬁle. By determining tear sIgA,
inducement of reﬂex tearing is easily detected because
tear sIgA concentrations decrease with reﬂex tear ﬂow
rate. Markoulli et al. found equal tear sIgA–total tear
ratios in WO and NST, which suggests that WO
samples do not signiﬁcantly induce reﬂex tearing.
Guyette’s study evaluated WO tear collection as a
replacement for capillary NST and applied this to com-
pare biomarker concentrations between ADDE and
non-ADDE patients.35,38,41,42
Indirect methods. Regarding indirect methods, collection
of PCTF is carried out using absorbing supports such
as Schirmer test strips (STS), ﬁlter paper disks, cellulose
sponges and polyester rods. The most common method
among them is STS collection.43
Inﬂammatory markers were analysed in the PCTF of
patients with ocular surface disease. Ten microliters of
tear was collected by a Weck-Cell Sponge. The concen-
trations of interleukin (IL)-1, IL-6 and pro-MMP-9
were measured by enzyme-linked immunosorbent
assay (ELISA), and the MMP-9 activity was evaluated
with gelatine zymography.44
Ophthalmic sponges and extraction buﬀers were
compared for quantifying cytokine proﬁles in tears
using Luminex technology. Luminex detection of cyto-
kine/chemokine proﬁles of tears collected with Merocel
sponges was found to be useful in clinical studies, for
instance to assess cytokine proﬁles evaluation in ocular
surface diseases.45
Samples obtained from the Schirmer procedure have
a higher mucus, lipid and cellular content than MCT
samples.46 STS also suﬀers incomplete, non-uniform
elution of proteins from the ﬁlter matrix.43 Although
micropipette and STS collection provide diﬀerent bio-
marker proﬁles for a given donor, the correctly applied
micropipette method is more consistent.47 STS is widely
accepted as the volume of sample collected with this
method is larger compared to other methods, but it
can cause reﬂexive tearing due to irritation, which
increases the volume of the samples, therefore aggra-
vates the detection of the investigated tear compo-
nent(s), e.g. drug concentrations.
In comparative studies tears of one and the same
patient are collected by several collection methods to
determine the same biomarkers from diﬀerent tear
samples.
Green-Church et al. collected tears using small
volume (1–5lL) Drummond glass MCT tubes with
1.6 slit-lamp magniﬁcation. Non-reﬂex tears were col-
lected from the inferior tear prism without contact with
the lower lid until a total of 5 lL were collected. During
a separate visit, tear collection was performed by
placing a STS over the lower lid. The lid was not
anesthetized and the STSs were placed approximately
6mm nasally from the lateral canthus. The subject was
instructed to close their eyes for the 5min test duration;
the wet length was not recorded but was observed to be
within reference ranges in all cases. The STS was then
placed in a 1.6mL amber Eppendorf tube at 4C until
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analysis. Their results suggest that the tear ﬁlm collec-
tion method does impact the proteins present in the
sample, so care should be exercised in choosing a tear
collection method in order to best correlate to the
experiment being conducted or the hypothesis being
tested.47
Lee et al. used two collection techniques for the com-
parative analysis of PCR assay to detect a pathogen,
namely herpes simplex virus 1.48 Tears were collected
from the lower fornix using STSs for 5min, a method
adopted in a previous study of Satpathy et al.49 The
other collection method was micro pipetting of tears,
after irrigating 100lL saline in the lower fornix. This
method was described in a previous study, where the
‘ﬂush’ tear collection technique was validated as a
viable alternative to basal and reﬂex tear collection.42
Based on their PCR results Lee et al. established that
PCR positive rate was not dependent on the tear col-
lection method or primers.48 Comparison of a direct
and an indirect method was performed by Jones et al.
They collected tears from healthy volunteers with either
porous polyester rods or glass capillary micropipettes.
Tear collection rate and recovery of two tear proteins,
EGF and lactoferrin, were compared in samples col-
lected with the two methods. Their results showed
that polyester rods collected tears an average of 3.9-
fold faster than glass capillary micropipettes, but this
diﬀerence was not statistically signiﬁcant. Lastly, they
suggested that polyester rods may have greater clinical
utility, facilitating routine analysis of the PCTF.50
Table 3 summarizes the diﬀerent tear collection meth-
ods published by various authors from the past few
years. All studies performed involved human
participants.
The main advantage of the direct sampling methods
is the straight way to collect tears from the ocular sur-
face, and the main disadvantages are the possible need
of dilution and the impossibility of sample collection
from detailed sites of tears. They may be diﬃcult to
perform in practice, but analytically they provide the
most proper analyte concentration of tears. The indir-
ect methods, however, are easy to implement, but ana-
lytically they do not inevitably represent the
biochemical characteristics of tears.
The critical aspects of tear sampling with respect
to the subsequent analysis
In the last decade, advances in proteomics/metabolo-
mics/lipidomics technologies have greatly expanded our
knowledge of the biochemical composition of the
ocular tear ﬂuid. To date, a number of tear proteins
and lipids have been identiﬁed as possible disease-
related biomarkers.51 The rapid development of various
‘omics’ methods facilitates the identiﬁcation and
examination of tear-based biomarkers. In some cases,
these techniques require speciﬁc sample collection,
handling and storage procedures. Hereunder we
would like to summarize the most commonly used
methods in proteomics and lipidomics with special
regard to their minimum sampling requirements.
Proteomics. Qualitative and quantitative tear protein
examination methods include one- and two-dimensional
gel electrophoresis, ELISA, high performance liquid
chromatography (HPLC), mass spectrometry (MS)
related techniques such as MS–MS, matrix-assisted
laser desorption/ionization time-of-ﬂight MS, surface-
enhanced laser desorption/ionization time-of-ﬂight MS,
liquid chromatography–MS, various antibody arrays,
multiplex bead analysis, Western blot analysis, etc.52,53
Using highly sensitive techniques – like isobaric tags for
relative and absolute quantitation – more than 500 tear
proteins have been identiﬁed so far.
Previous studies have indicated that sample handling
variables such as sample collection conditions and time,
storage temperature and time, storage tube, freeze/thaw
cycles and protease inhibitors have signiﬁcant eﬀects on
the results of protein analysis.54 In general, sample col-
lection should be scheduled at the same time of day
(e.g. early morning) and samples should be transferred
onto dry ice immediately after sampling to prevent pro-
tein degradation. Addition of protective or stabilizing
compounds (reducing agents, protease and peptidase
inhibitors, etc.) would be desirable but inhibitor cock-
tails may interfere with the subsequent MS analysis.
The collected samples should be aliquoted and stored
with minimization of thaw/refreeze cycles, preferably at
80C.55 Theoretically, the frozen samples (at 20 to
80C or in liquid nitrogen) can be stored for years
protected from degradation.56
Another critical aspect of tear analysis is the limited
volume of the samples and the relatively low number of
proteins of interest. In addition, the stimulus conditions
(NST versus ST) and collection technique can strongly
aﬀect the protein proﬁle and volume of the tear sample.
Fullard and Snyder observed that the concentrations of
eight proteins (IgA-SC, IgA1, IgA2, IgM, IgG, IgA,
transferrin, serum albumin) from the 12 analysed tear
proteins showed signiﬁcantly higher concentrations in
NST, and only four (lactoferrin, tear-speciﬁc prealbu-
min, peroxidase, lysozyme) were in similar concentra-
tions in both types of tears.38 On the other hand, the
total tear protein content of NST samples decreased
from 9.1 to 6.0 g/L in the ST ones.37 These data indicate
that the diluting eﬀect of reﬂexive tearing has a decisive
eﬀect on the quantitative composition of the tear
sample and highlights the importance of controlling
tear ﬂow rate during tear collection.55 Based on the
above observation NST sampling seems to be more
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beneﬁcial unless the experimental goal is the investiga-
tion of ST tears or reﬂexive tearing.
Lipidomics. While the protein composition of the human
tear has been described in great detail, the lipidomic
analysis of the tear is noticeably lagging behind due
to the low lipid content of the tear ﬂuid.57 Because of
the various diﬃculties (lipid diversity and complexity,
chemical stability or instability of diﬀerent types of
lipids) the qualitative and quantitative analysis of tear
lipids is a diﬃcult task.
Regarding the technical limitations (sensitivity and
performance of the method; volatility and stability of
intact lipids) the commonly used analytical methods –
gas chromatography–mass spectroscopy and liquid
chromatography–mass spectrometry (LC/MS) – are
not suﬃciently eﬃcient and accurate for the lipidomic
analysis of the human tear. HPLC and its newer and
faster ‘relative’, ultra-high performance liquid chroma-
tography (UPLC) mass spectrometry (HPLC/MS and
UPLC/MS) and atmospheric pressure ionization MS
are more suitable methods for the examination of
intact lipids in tear ﬂuid.58 Nuclear magnetic resonance
spectroscopy, Raman and infrared spectroscopy may
also be used as alternative approaches, although their
sensitivity and selectivity is far below that of MS.4,58
The requirements of sample collection are the same
as in the case of protein determination. The samples
should be stored frozen at 80C or lower, multiple
melting of the samples should be avoided and the sam-
ples should be handled in deeply frozen conditions (e.g.
at 80C) until assessment. During the examination of
lipids that are sensitive to light or the O2 content of the
air – such as retinoids – special attention is needed, e.g.
usage of amber-coloured Eppendorf tubes.58 Basal tear
collection using capillary tubes is recommended for tear
lipid analysis as the concentration of several lipid
classes is below the limit of detection in reﬂex and
ﬂush tears.59
Conclusions
Biomarker-based diagnostics, as well as personalized
medicine utilizing its results are becoming more
widely used in modern medicine. In addition to the
‘classical’ sampling methods (e.g. biopsy), there is a
growing demand for fast, painless and non-invasive
sampling procedures such as examination of various
easily accessible body ﬂuids. The identiﬁcation and
potential application of biomarkers carried by urine,
sweat, amniotic ﬂuid and last but not least precorneal
tear are the subjects of intensive interest and research
nowadays.
Similarly to other newly developed methods, precor-
neal tear analysis has no standard methodology.
Sampling techniques used by diﬀerent research groups
are not exceptions to this rule. Both the investigation of
‘tear physiology’ and tear biomarker research are based
on the biochemical characterization of so-called basal
(or NST) tears, which diﬀer from ST tears (also known
as reﬂex tears) both in terms of quantitative and quali-
tative biochemical characteristics. In practice, two
quickly and easily adaptable sampling methods, the
STS and the MCT technique are widely used for the
collection of NST. Based on the previous statements
the authors unequivocally recommend the capillary-
collected NST sampling method for protein content
determination since it represents the most accurate pro-
tein concentration of tears. For lipid content determin-
ation, NST is the most commendable sampling method
as well, but in this case glass or polished micropipette is
also available. There are no special considerations for
mucin analysis as they consist of glycocalyx expressed
by epithelial tissues of mucous surface and there is no
direct simple method to evaluate ocular surface
glycocalyx.
Since the STS method triggers more or less intense
tearing, this technique is suitable for the isolation of a
mixed sample containing NST and ST. Thus, the ana-
lysis of samples collected by the STS method does not
necessarily represent the biochemical properties of NS
tears.
In the last decade, numerous studies have addressed
the comparison of STS and MCT methods. It was
observed in the late 1960s that the STS method may
underestimate the actual protein concentrations of tears
due to increased ﬂuid ﬂow. Some studies have since
revealed that not only the diluting eﬀect of reﬂex tear-
ing, but also the protein binding and retention capacity
– which is strongly associated with the molecular
weight and hydrophobic surface area of the studied
proteins – of STS paper is responsible for the lower
protein content of STS samples. The STS method
modiﬁes both the quantitative and the qualitative char-
acteristics of tear samples. In the late 1970s and 1980s,
various research groups reported elevated concentra-
tions of certain proteins – like albumin, IgG, transfer-
rin, urokinase and plasmin as well as various
intracellular enzymes involved in metabolism such as
aspartate aminotransferase and alanine aminotransfer-
ase, lactate dehydrogenase, aldolase, glucose-6-
phosphate dehydrogenase – in the STS-collected tears
compared to MCT samples. Comparing the proteome
of tear samples collected by MCT and STS methods
Green-Church et al. found that more than 50 diﬀerent
proteins were detected exclusively in the STS samples
(MCT-speciﬁc proteins: 13; STS-speciﬁc proteins: 54;
overlapping proteins: 30; total: 97 proteins; determin-
ation: in-gel tryptic digestion followed by liquid
chromatography–tandem mass spectrometry and
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multidimensional protein identiﬁcation technology).
Several studies have conﬁrmed that the STS method –
which often triggers irritation in the lower cul-de-sac of
the eye – changes the protein composition of tears by
injuring the conjunctival surface and microvasculature.
In contrast to STS-based sampling, the MCT tech-
nique is believed to be a less invasive procedure. If it is
performed by a specialist who has practice and experi-
ence in this collection method, the MCT technique does
not induce reﬂex tearing, nor does it involve a potential
risk of injury. Therefore, the MCT sampling method is
more suitable for the collection of NST than the STS
procedure. On the other hand, some researchers have
highlighted the following disadvantages of the MCT
method: the sampling is interrupted by blinking; STS
could be more pleasant for the test subjects than the
capillary tube; the investigator has to hold the capillary
tube for the duration of the sampling procedure, which
entails constant and prolonged work on the open eye.
For the compensation of low sample volume, several
research groups use the so-called WO method, in which
the tears are ‘ﬂushed out’ through the addition of
exogenous ﬂuid (e.g. sterile physiol. saline). The dilut-
ing eﬀect of the WO method is reﬂected by the sup-
pressed concentrations and the decreased variances of
the most abundant cytokines (e.g. IL-8, IL-1 and
vascular endothelial growth factor). In addition, the
concentrations of ‘minor’ tear components drop
below the detection limit and the slight diﬀerences
between the samples become unrecognizable.
Therefore, the WO method can be used successfully
only in those experiments which target proteins found
in high concentration in tears.
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